Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D
Related Posts
Hero Destini 125 Azure Concept showcased at Bharat Mobility 2025
By: Sameer Fayaz Contractor | Updated on: 22 Jan 2025, 15:12 PM
2025 in review: How we elevated the Microsoft Store experience
By Giorgio Sardo Publication Date: 2025-12-18 17:00:00 2025 was a meaningful year for the Microsoft Store on Windows, with more than 250 million monthly…
Exciting New Simulation Technology: Speedy, Adaptable, and Scalable – On the Cloud – Digital Engineering
The adoption of cloud computing has led to an increased demand for purpose-built hardware for high-performance computing (HPC) requirements in…